EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 2.426
March 31, 2026 2.317
December 31, 2025 2.126
September 30, 2025 1.954
June 30, 2025 1.968
March 31, 2025 2.039
December 31, 2024 2.029
September 30, 2024 2.041
June 30, 2024 2.006
March 31, 2024 1.744
December 31, 2023 1.618
September 30, 2023 1.721
June 30, 2023 1.543
March 31, 2023 1.463
December 31, 2022 1.290
September 30, 2022 1.072
June 30, 2022 1.014
March 31, 2022 0.8347
December 31, 2021 0.8437
September 30, 2021 0.757
June 30, 2021 0.4949
March 31, 2021 0.0651
December 31, 2020 -0.1843
September 30, 2020 -0.5315
June 30, 2020 -0.5389
Date Value
March 31, 2020 -0.0736
December 31, 2019 0.0932
September 30, 2019 0.332
June 30, 2019 0.6952
March 31, 2019 0.7837
December 31, 2018 0.7755
September 30, 2018 0.7429
June 30, 2018 0.3713
March 31, 2018 0.3515
December 31, 2017 0.57
September 30, 2017 0.61
June 30, 2017 0.70
March 31, 2017 0.67
December 31, 2016 0.45
September 30, 2016 0.42
June 30, 2016 0.51
March 31, 2016 0.52
December 31, 2015 0.54
September 30, 2015 0.60
June 30, 2015 0.67
March 31, 2015 0.59
December 31, 2014 0.54
September 30, 2014 0.49
June 30, 2014 0.44
March 31, 2014 0.44

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Globus Medical, Inc. 3.911
Baxter International, Inc. -1.928
DexCom, Inc. 2.533
Haemonetics Corp. 2.050
ICU Medical, Inc. 1.184